Storys zum Thema Medikament
- 2Ein Dokumentmehr
- 2
Record financing rounds at the Munich biotech hub
Ein Dokumentmehr canSERV relaunches Open Call for Service Provision
Ein DokumentmehrPress release: STADA continues strong growth journey in the first half of 2024
Ein Dokumentmehr- 4
Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science Prizes
Ein Dokumentmehr Press release: Alvotech and STADA add to strategic alliance through denosumab partnership
Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
Ein DokumentmehrPress release: STADA welcomes CHMP positive opinion on extending indication for Kinpeygo
STADA welcomes CHMP positive opinion on extending indication for Kinpeygo - The CHMP adopted a positive opinion recommending a change to the terms of the marketing authorization of Kinpeygo for the treatment of adults with primary immunoglobulin A, now covering patients with a UPCR of ≥0.8 g/g - ...
Ein DokumentmehrPress release: Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK - Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® ...
Ein DokumentmehrcanSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr- 3
canSERV invites applications for "Revolutionising Cancer Patient Care"
Ein Dokumentmehr Press release: STADA continues with double-digit sales and profit growth in 2023
Ein Dokumentmehr- 2
PM: DHL Global Forwarding transportiert für kinderherzen die weltweit erste mobile Herzklinik nach El Salvador / PR: DHL Global Forwarding supports NGO kinderherzen to deliver world’s first mobile heart clinic to El Salvador
2 Dokumentemehr Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
Ein DokumentmehrPress release: STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
Ein DokumentmehrPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Ein Dokumentmehr- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
Ein Dokumentmehr - 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
Ein Dokumentmehr - 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
Ein Dokumentmehr Press release: STADA and Xbrane launch ranibizumab to support patient access in Europe
STADA and Xbrane launch ranibizumab to support patient access in Europe - Ranibizumab biosimilar is being launched in major European markets - Ranibizumab is the first product brought to market through a strategic collaboration between STADA and Xbrane, marking Xbrane’s first commercial launch and ...
Ein Dokumentmehr- 5
Press Release - hubergroup India expands its support for rural healthcare
Ein Dokumentmehr Press release: STADA sustains strong momentum with double-digit sales and profit growth in 2022
Ein DokumentmehrFree Access to Cancer Research Services - canSERV 1st Call for Proposals
Ein DokumentmehrInnovation and Start-up Center Biotechnology (IZB) welcomes Invitris
Ein DokumentmehrPress release: EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
Ein DokumentmehrPress release: Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe
Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...
Ein DokumentmehrGerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
Ein DokumentmehrPress release: STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis®
STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis® - European Commission grants pan-EU marketing authorization for Ximluci® biosimilar referencing Lucentis® (ranibizumab) - Paves way for European ...
Ein DokumentmehrAM plays to its strengths in the medical field
Ein Dokumentmehr